XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (32,159,000) $ (2,061,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 38,299,000 49,198,000
Depreciation and amortization 9,585,000 9,086,000
Provision (recovery) for bad debts 921,000 (26,000)
Deferred income taxes (3,302,000) (1,578,000)
Non-cash lease expense 2,604,000 2,954,000
Amortization and accretion of marketable securities (5,579,000) (7,991,000)
Other 2,199,000 3,080,000
Change in operating assets and liabilities:    
Accounts receivable (2,338,000) 3,037,000
Prepaid expenses and other assets (1,064,000) (8,068,000)
Deferred commissions 260,000 1,509,000
Other assets 982,000 669,000
Accounts payable 900,000 (2,897,000)
Accrued expenses and other liabilities 801,000 (2,096,000)
Accrued interest (6,877,000) (6,848,000)
Deferred revenue 467,000 (747,000)
Operating lease liabilities (2,454,000) (3,978,000)
Net cash provided by operating activities 3,245,000 33,243,000
Cash flows from investing activities    
Purchases of property and equipment (976,000) (473,000)
Acquisition of business, net of cash acquired 0 (12,040,000)
Capitalized internal-use software costs (5,023,000) (7,191,000)
Purchases of marketable securities (401,632,000) (480,085,000)
Sales of marketable securities 983,000 0
Paydowns, maturities, and redemptions of marketable securities 493,521,000 452,711,000
Net cash provided by (used in) investing activities 86,873,000 (47,078,000)
Cash flows from financing activities    
Repurchase of common stock (94,105,000) (37,635,000)
Proceeds from exercise of stock options 2,506,000 1,522,000
Payments of tax withholdings on net settlement of equity awards (5,879,000) (11,106,000)
Proceeds from issuance of stock under employee stock purchase plan 1,665,000 3,625,000
Payment of acquisition-related non-employee investor holdback consideration (928,000) 0
Net cash used in financing activities (96,741,000) (43,594,000)
Net decrease in cash and cash equivalents (6,623,000) (57,429,000)
Beginning of period 218,432,000 283,043,000
End of period 211,809,000 225,614,000
Supplemental disclosure of non-cash activities    
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ 7,148,000 $ 1,248,000